InsidersTradesSigma
Track the MAYNE PHARMA GROUP LIMITED share price and the full management transaction log of the company, a publicly traded company based in Australia. Shares are listed on AU AU, under the authority of ASX. Market capitalisation: €223.4m. The latest transaction was disclosed on 25 June 2026 (Change in Substantial Holding). Among the most active insiders: Funicular Funds, LP. All data is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
MAYNE PHARMA GROUP LIMITED is an Australian pharmaceutical company focused on the development and commercialization of generic and branded pharmaceutical products. It is listed on the Australian Securities Exchange under the ticker MYX.